SRF Ltd's Q2 FY27 numbers came in strong, with revenue of Rs. 4,904.20 Cr (+34.70% YoY) and PAT growth of +31.20% YoY. Here's a quick read of what worked, what to watch, and what management said.
| Results date | October 21, 2026 |
|---|---|
| Quarter | Q2 FY 2026-2027 |
| Revenue (Q2) | Rs. 4,904.20 Cr (+34.70% YoY) |
| PAT (Q2) | Rs. 509.12 Cr (+31.20% YoY) |
| EBITDA margin | 19.29% (-198 bps YoY) |
| EPS (Q2) | Rs. 17.18 (+31.10% YoY) |
| Market cap | Rs. 68,602.37 Cr |
| CMP | Rs. 2,305.00 |
SRF delivered its highest-ever Q2 revenue of Rs.4,904 Cr, up 34.7% YoY, with PAT up 31.2% to Rs.509 Cr, while the guided seasonal step-down and PF&F margin normalisation to 9.7% materialised as management expected. Chemicals grew 24.7% YoY with a 25.4% EBIT margin, tracking at/above the guided 15-20% FY27 range, and H1 PAT of Rs.1,268 Cr already covers 69% of FY26's full-year PAT. EBITDA margin compressed 198 bps YoY to 19.29% and H1 free cash flow turned negative at Rs.−180 Cr on Rs.974 Cr of capex against a ~Rs.2,500 Cr FY27 plan.
Disclaimer: This results analysis is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.